Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131260 · ClinicalTrials.gov registry record · NA
Fetal ST Segment and T Wave Analysis in Labor
A NA study of Pregnancy and Obstetric Labor, sponsored by The George Washington University Biostatistics Center.
- Completed
- Registry status
- NA
- Development phase
- 11,108
- Enrollment target
- 13
- Study locations
NCT01131260: Completed NA study of Pregnancy and Obstetric Labor, sponsored by The George Washington University Biostatistics Center.
NCT01131260 is a NA study of Pregnancy and Obstetric Labor that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 11,108 participants, above the 815-participant average among 191 other Pregnancy trials with a reported enrollment target (1263% higher). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01131260, a NA study of Pregnancy and Obstetric Labor, has completed, sponsored by The George Washington University Biostatistics Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,108 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this research is to test a new instrument, called a fetal STAN monitor, that may be used during labor to monitor the electrical activity of the baby's heart. This new instrument is designed to help the doctor determine how well the baby is doing during labor. It will be used along with the existing electronic fetal monitor used to measure the baby's heart rate and the mother's contractions during birth. The specific purpose of this research study is to see if this new instrument (fetal STAN monitor) will have an impact on newborn health.
Primary Outcome
Composite primary outcome of intrapartum fetal death, neonatal death, Apgar score \<=3 at 5 minutes, neonatal seizure, umbilical artery blood pH \<= 7.05 with base deficit \>=12 mmol/L in extra-cellular fluid, intubation for ventilation at delivery, neonatal encelphalopathy
Conditions Studied
Interventions
- DEVICE fetal STAN monitor
Study Locations (13)
Ohio
- Case Western University - Cleveland
- Ohio State University - Columbus
Texas
- University of Texas - Galveston - Galveston
- University of Texas - Houston - Houston
Alabama
- University of Alabama - Birmingham - Birmingham
Illinois
- Northwestern University - Chicago
Michigan
- Wayne State University - Hutzel Hospital - Detroit
New York
- Columbia University - New York
North Carolina
- University of North Carolina - Chapel Hill - Chapel Hill
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,108 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-08 |
| Phase | NA |
What the finished NCT01131260 record still lists
NCT01131260 is an interventional study that assigns participants to a tested intervention. Its 11,108 participants enrollment target places it among the larger protocols in the corpus, above the 815-participant average among 191 other Pregnancy trials with a reported enrollment target (1263% higher).
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which fetal STAN monitor is the first listed.
NCT01131260 lists 13 locations in 11 states (Ohio, Texas, Alabama).
Frequently Asked Questions
What is clinical trial NCT01131260 about?
NCT01131260 is a clinical study titled "Fetal ST Segment and T Wave Analysis in Labor". The purpose of this research is to test a new instrument, called a fetal STAN monitor, that may be used during labor to monitor the electrical activity of the baby's heart. This new instrument is designed to help the doctor determine how well the baby is doing during labor. It will be used along wit...
What is the current status of trial NCT01131260?
This trial is currently completed. It is a NA study. The enrollment target is 11,108 participants. The study started on 2010-11. Estimated completion is 2014-08.
What conditions does trial NCT01131260 study?
This clinical trial studies the following conditions: Pregnancy, Obstetric Labor, Parturition.
What interventions are being tested in trial NCT01131260?
The interventions under investigation include: fetal STAN monitor (DEVICE).
Who is sponsoring clinical trial NCT01131260?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01131260 being conducted?
This trial has 13 study locations across Alabama, Illinois, Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01131260's enrollment target sits among peer trials
11,108 3rd of 191 higher than 189 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- NCT07181109 · 11,000 participants · Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- NCT06677060 · 11,300 participants · Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia